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Abstract
Introduction There is increasing recognition of the role of the
microenvironment in the control of both normal and tumour cell
behaviour. In the breast, myoepithelial cells and fibroblasts can
influence tumour cell behaviour, with myoepithelial cells
exhibiting a broad tumour-suppressor activity while fibroblasts
frequently promote tumour growth and invasion. This study
describes the development of physiologically relevant three-
dimensional heterotypic culture systems containing mixed
normal or tumour-derived breast populations and shows how
such models can be used to dissect the interactions that
influence cell behaviour.
Methods Populations of luminal cells, myoepithelial cells and
fibroblasts were isolated from normal and malignant breast
tissue, characterised and compared with immortalised cell lines.
Co-localisation of normal and malignant luminal cells with
myoepithelial cells alone or with either normal or tumour-derived
fibroblasts was studied. Cultures were grown for seven days,
and then gels were fixed and whole gel immunofluorescence
carried out to assess co-localisation and polarisation. The
potential role of matrix metalloproteinases (MMP) or hepatocyte
growth factor(HGF)-c-met signalling in disrupting cellular
organisation was investigated by incorporating inhibitors into
cultures either alone or in combination.
Results Over a culture period of seven days, myoepithelial cells
organised themselves around luminal cell populations forming
dual-cell co-units. Characterisation of co-units showed
established basal polarity and differentiation analogous to their
in vivo counterparts. Tumour cell co-units revealed subtle
differences to normal co-units including disruption of basement
membrane and loss of 4-integrin, as described in ductal
carcinoma in situ (DCIS) in vivo. Inclusion of normal fibroblasts
had no influence on co-unit formation; however, inclusion of
tumour-associated fibroblasts lead to disruption of co-unit
organisation, and this was significantly inhibited in the presence
of MMP and/or c-met inhibitors.
Conclusions To the best of the authors' knowledge, this study
describes for the first time a co-culture model comprising three
major components of normal and malignant breast: luminal cells,
myoepithelial cells and stromal fibroblasts. These cells organise
into structures recapitulating normal and DCIS breast, with
homing of myoepithelial cells around the luminal population.
Importantly, differences are exhibited between these systems
reflecting those described in tissues, including a central role for
tumour-associated fibroblasts and MMPs in mediating
disruption of normal structures. These findings support the value
of these models in dissecting normal and tumour cell behaviour
in an appropriate microenvironment.
Introduction
Over the past decade the importance of the microenvironmen-
tal control of tumour cell progression has been increasingly
recognised. The microenvironment within the breast is com-
plex, consisting of a stromal component, the major cell type of
which is the fibroblast along with inflammatory cells and blood
3D: three dimensional; BSA: bovine serum albumin; DAPI: 4',6-diamidino-2-phenylindole; DCIS: ductal carcinoma in situ; DMEM: Dulbecco's modi-
fied eagle's media; DMSO: dimethyl sulfoxide; DSc3: desmocollin-3; ECM: extracellular matrix; EMA: epithelial membrane antigen; FBS: fetal bovine 
serum; HGF: hepatocyte growth factor; MMP: matrix metalloproteinase; PBS: phosphate buffered saline; SMA: smooth muscle actin; TAF: tumour-
associated fibroblast; TN-C: tenascin-C.Breast Cancer Research    Vol 11 No 1    Holliday et al.
Page 2 of 11
(page number not for citation purposes)
vessels. In addition, there is a non-neoplastic epithelial compo-
nent in the myoepithelial cell that lies between the luminal cell
layer and the basement membrane. Both of these cell types
are known to influence tumour progression; tumour-associ-
ated fibroblasts (TAFs) have been shown to promote tumour
cell invasion [1-3], release extracellular matrix (ECM) degrad-
ing proteases [1,4,5] and modify the composition of the ECM
facilitating tumour cell motility [6]. In contrast, myoepithelial
cells which form a barrier between tumour cells and the sur-
rounding stroma are believed to play a tumour-suppressing
role. This could in part be due to the ability of myoepithelial
cells to decrease tumour cell proliferation and increase apop-
tosis, and to reduce tumour cell invasion and protease expres-
sion in vitro [7,8].
The exact role of these cell types, interacting both with each
other and with the tumour cell, in the progression of breast
cancer has yet to be fully understood; however, it is likely that
the influence of each of these cell types differs during the
stages of breast cancer, for example, myoepithelial cells are
present in ductal carcinoma in situ (DCIS) but are lost in the
progression to invasive carcinoma. Furthermore, the function
of the cells of the microenvironment may change during evolu-
tion of the tumour, because genetic and phenotypic differ-
ences have been identified in these populations in tumour
tissues compared with normal tissues [6,9]
Over recent years there has been a shift towards examining
cells in physiologically relevant matrices that are able to more
faithfully recapitulate the multi-cell three-dimensional (3D)
environment of breast carcinomas in vivo [10]. Culturing cells
in 3D has been shown to have dramatic effects on cell polarity
and differentiation as well as signalling cascades and gene
expression profiles compared with that seen in monolayer cul-
ture [11-13]. Studies of mammary epithelial cells grown in the
basement membrane equivalent, Matrigel, have allowed a
deeper understanding of mammary gland development and in
particular the key roles played by molecules such as the
integrins and laminin in maintaining tissue architecture and cell
polarity in the normal breast [12,14]. Furthermore this
approach has permitted the identification of proteins or recep-
tors which are altered in cancer, such as up-regulation of 1-
integrin, with reversion to a normal phenotype when the
actions of this integrin are blocked [13].
Fibroblasts have been more widely studied in 3D, most fre-
quently in a collagen matrix, which is more representative of
their physiological stromal surrounding [14,15]. As well as
being morphologically very different in 3D because of the loss
of the enforced polarity seen in 2D cultures, they form novel
matrix adhesions with the ECM rather than fibrillar or focal
adhesions seen in monolayers [15]. Thus modelling of tumour
biology is cell-type and stroma-context dependent, and altera-
tions of these from a 2D to a more physiological 3D system
produces striking changes.
Although current 3D models of breast cancer are a consider-
able improvement on 2D systems, they are limited in focussing
on the behaviour of one cell type in 3D or, at best, on the inter-
actions between two cell types [16-18]. The complex nature
of the stromal component in the breast means that the study
of one or two cell types is unlikely to recapitulate what is seen
in vivo. For example, the balance between the tumour suppres-
sor role of myoepithelial cells and the pro-invasive role of
fibroblast populations cannot be gauged in a two-cell system.
To our knowledge, no published model has included all three
cell populations in one system. This study describes a repro-
ducible system developed to co-culture normal or malignant
epithelial cells, myoepithelial cells and fibroblast populations in
an appropriate ECM, validates the architectural and functional
recapitulation of the in vivo phenotype, and demonstrates the
application of such a model in dissecting cellular interactions.
This provides a physiologically relevant in vitro model system
to study the role of the microenvironment in the normal and
malignant breast.
Materials and methods
Breast tissue and cell lines
Breast tissue was obtained from women undergoing surgery
for breast carcinoma or reduction mammoplasty after informed
consent was given and the study was approved by the North
East London Ethics Committee. None of the patients had
received pre-operative chemotherapy.
The breast cancer cell line, MCF-7, and the human fetal fore-
skin fibroblast cell line, hfff2, were obtained from the American
Type Culture Collection (Rockville, Maryland). The myoepithe-
lial (MYO1089), luminal epithelial (HB4a) and fibroblast
(HMFU19) cell lines were a gift from Professor Mike O'Hare
(Ludwig Institute, London, UK). These lines were generated
from isolated primary cell populations by transduction with
SV40 large T antigen [19].
Isolation of primary cell populations
Tissue, excess to histopathological diagnosis, was selected
from the breast samples and fibroblasts were isolated as
described previously [20]. Briefly, the tissue was digested for
12 hours in Dulbecco's modified eagle's media (DMEM), 10%
fetal bovine serum (FBS), 2MM L-Glutamine, 100 IU penicillin
and streptomycin, 400 IU collagenase IA and 65IU hyaluroni-
dase (all reagents obtained from Sigma-Aldrich Company Ltd.,
Poole, Dorset, UK). Following a sedimentation step at 1g for
30 minutes, the supernatant was removed from the organoid
portion and centrifuged, washed twice in serum-free DMEM
then filtered through a 20 m cell strainer (BD Falcon, San
Diego, California, USA). The filtrate was spun down and the
cell pellet resuspended in DMEM with 10% FBS, penicillin
and streptomycin (100 U/ml) and fungizone (2.5 g/ml) (Gibo-
BRL, Invitrogen, Corporation, Carlsbad, CA, USA). The cells
were cultured for 24 hours then the medium was aspirated offAvailable online http://breast-cancer-research.com/content/11/1/R3
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and the cells were washed with DMEM, (to remove any non-
viable cells or contaminating red blood cells) before re-feeding
with complete DMEM.
The residual organoids were washed twice in serum-free
DMEM (Sigma-Aldrich Company Ltd., Poole, Dorset, UK) and
plated into either luminal media (RPMI 1640, Sigma-Aldrich
Company Ltd., Poole, Dorset, UK) or myoepithelial media
(Hams F12 Nutrient mix, Sigma-Aldrich Company Ltd., Poole,
Dorset, UK) and cultured for four to seven days until cells
could be observed growing out from the organoids. Cells were
then trypsinised and resuspended in PBS/0.1% BSA contain-
ing immunomagnetic beads labelled with 4-integrin or epithe-
lial membrane antigen (EMA) to isolate myoepithelial and
luminal cells, respectively as previously described [21]. The
resulting cell populations were cultured in cell specific media
[20] and used within two passages.
Characterisation of cell populations
Cells plated onto poly-l-lysine coated coverslips were stained
with antibodies to vimentin (clone 384, Dako UK Ltd, Ely, UK),
Cytokeratin 14 (clone LL002, AbD Serotec, MorphoSys, Kid-
lington, UK), Cytokeratin 18 (clone CY90, AbD Serotec, Mor-
phoSys, Kidlington, UK), CK17 (clone CK-E3, Sigma-Aldrich
Company Ltd., Poole, Dorset, UK), CK5/6 (clone D5/16 B4,
Dako UK Ltd, Ely, UK), EMA (clone E29, Dako UK Ltd, Ely,
UK), -smooth muscle actin (–smooth muscle actin (SMA),
clone 1A4 Dako UK Ltd, Ely, UK), E-cadherin (NCH-38, Dako
UK Ltd, Ely, UK), DSG-2 (Progen), DSG-3 (clone 5H10,
Autogen Bioclear, Calne, UK), 4 integrin (clone 439-9B,
Chemicon, Millipore, Watford, UK), CD45 (clone 2B11/PD7/
26, Dako UK Ltd, Ely, UK) and CD31 (clone JC70A, Dako UK
Ltd, Ely, UK). Fluorescein isothiocyanate-conjugated rabbit
anti-mouse F(ab1)2 (Dako UK Ltd, Ely, UK) was used as sec-
ondary and 4',6-diamidino-2-phenylindole (DAPI) (Calbio-
chem) as a nuclear counterstain. Omission of the primary
antibody was included as a negative control. Images were
recorded on a Zeiss Axiovert 200M confocal microscope
using the LSM510 Meta software (Carl Zeiss, Jena, Germany).
Construction of heterotypic 3D collagen gel cultures
Myoepithelial cells and fibroblasts were labelled with 5 g/ml
cell tracker (Cell tracker red CMTMR or Cell tracker green
CMFTA respectively, Molecular Probes Invitrogen, Corpora-
tion, Carlsbad, CA, USA) 24 hours before use.
Luminal cells (3.3 × 105) were resuspended in 2 mls of DMEM
and aggregated over agar for two hours at 37°C / 5% carbon
dioxide. An equal number of myoepithelial cells labelled with
red cell tracker was then added to the luminal population and
cells aggregated for a further two hours. Aggregates were
centrifuged gently at 500 rpm for three minutes and resus-
pended in 1 ml of collagen with or without fibroblasts.
Rat tail collagen I (BD Biosciences, New Jersey, USA) was
adjusted to a concentration of 1 mg/ml by diluting with Dul-
becco's PBS. Eight parts of collagen were then mixed with
one part 10 × Hank's Buffered Salt Solution (Sigma-Aldrich
Company Ltd., Poole, Dorset, UK). Sodium hydroxide was
added drop-wise to neutralise the pH (judged by eye when the
mixture turned from yellow to orange-red). One volume of
DMEM with or without 3.3 × 105/ml fibroblasts was added
and mixed into the gel by gentle pipetting. Into each 10 mm
diameter MatTek dish (MatTek Corporation, US) 100 l of the
gel mixture was pipetted and left to solidify for 10 minutes at
37°C / 5% carbon dioxide before being covered with 1.5 ml
complete DMEM. Gels were cultured for seven days, media
was replaced every two to three days during this time. Follow-
ing optimisation, selected cultures were carried out using ani-
mal-free reagents.
For experiments investigating formation of co-units, a time
course experiment was carried out whereby 3.3 × 105 cells of
each population were mixed together as a single cell suspen-
sion without pre-aggregation of individual populations. The
admixed cells were resuspended in collagen and cultured as
described above and cells were fixed at day 1 (D1), D3, D5
and D7.
Experiments including inhibitors to c-met and matrix metallo-
proteinases (MMP) were set up as for the time course experi-
ment (n = 3 for each condition). A selective inhibitor for the
hepatocyte growth factor (HGF) receptor, c-met, (100 nM,
PHA 665752, Tocris) and/or a broad spectrum MMP inhibitor
(10 M, GM6001, Chemicon, Millipore, Watford, UK) was
included in the media at D1 with additional inhibitor added at
D3 and D5. Cultures containing a vehicle control of 10 M
dimethyl sulfoxide (DMSO) (Sigma-Aldrich Company Ltd.,
Poole, Dorset, UK) were also included.
Generation of fibroblast conditioned media
Fibroblasts were plated into 25 cm2 tissue culture flasks and
grown to 60% confluency, the media removed, cells washed
with Dulbecco's PBS and 5 ml serum-free DMEM was added.
Fibroblasts were then cultured for a further 48 hours, media
removed and centrifuged to remove cell debris and stored at -
80°C until use.
Fixation of gels and whole gel immunofluoresence
Gels were washed in PBS (three times for five minutes), fixed
in 4% paraformaldehyde (Fisher Scientific, Loughborough,
UK) for 30 minutes at room temperature and then permeabi-
lised with 0.5% triton X-100 (Sigma-Aldrich, Company Ltd.,
Poole, Dorset, UK) in PBS for 30 minutes at room tempera-
ture. Immunofluorescence was carried out on whole gels con-
tained within the MatTek dishes. Non-specific binding was
blocked with normal goat serum for 10 minutes before incuba-
tion with a primary antibody, E-cadherin, EMA, Tenascin-C
(TN-C; Clone BC24, Sigma-Aldrich Company Ltd., Poole,Breast Cancer Research    Vol 11 No 1    Holliday et al.
Page 4 of 11
(page number not for citation purposes)
Dorset, UK) and 4-integrin for 90 minutes at room tempera-
ture. Secondary antibody (goat anti-mouse Alexa 488) was
incubated for 30 minutes at room temperature along with the
nuclear stain DAPI and gels were gently compressed between
the dish and a coverslip. Images were captured on the confo-
cal microscope.
Assessment of co-unit formation and basal polarity
In experiments assessing co-unit formation the number of co-
units formed (defined as an aggregate where at least 70% of
the luminal (or MCF-7) cells are surrounded by myoepithelial
cells) in 10 microscopic fields was counted and an average of
co-units/10 fields calculated.
For assessment of basal polarity the number of co-units
expressing 4 integrin and TN-C (basement membrane depo-
sition) was counted in 10 fields and data expressed as a per-
centage of the total co-units.
Results
Isolation and characterisation of primary breast cell 
populations and cell lines
Fibroblast, luminal epithelial and myoepithelial cell populations
were isolated from reduction mammoplasty material (n = 12)
and breast cancer tissue removed (n = 12). In the tumour
donor cases, the fibroblasts were isolated from within the car-
cinoma (i.e. TAFs).
The phenotype of different cell populations and an estimate of
purity was established by immunostaining. Primary myoepithe-
lial cells showed expression of basal-associated cytokeratins-
14, -17 and -5/6 and the myoepithelial associated 4-integrin
(Figure 1a). The myoepithelial-restricted desmoglein-3 was
expressed along with desmoglein-2 and E-cadherin. Myoepi-
thelial cells showed characteristic expression of the mesen-
chymal marker vimentin but were negative for the luminal
epithelial-associated EMA and CK18. There was a down-reg-
ulation of -SMA expression in the isolated myoepithelial cells
compared with their tissue counterparts. The myoepithelial cell
line MYO1089 exhibited an identical expression profile as pri-
mary myoepithelial cells (data not shown).
Isolated luminal cells showed expression of the luminal cytok-
eratin 18 and the luminal epithelial-associated EMA, with
membranous staining for desmoglein-2 and E-cadherin. The
cells were negative for the myoepithelial and fibroblast mark-
ers (Figure 1b). The luminal cell line HB4a showed the same
expression profile as the primary luminal cells (data not
shown).
The isolated fibroblasts stained uniformly for vimentin and
were negative for the luminal epithelial and myoepithelial mark-
ers, the endothelial-associated CD31 and the pericyte and
vascular smooth muscle-related alpha1-integrin (Figure 1c).
The fibroblasts were also negative for the leucocyte marker
CD45 (not shown). A proportion of the fibroblasts in any given
isolate were positive for -SMA (about 20%) and this was
comparable between normal and TAF's. The fibroblast cell
lines HMFU19 and hfff2 showed the same expression pattern
as primary cells (data not shown).
Luminal and myoepithelial cells form dual-cell co-units
After seven days in culture, collagen gels were harvested to
examine structural morphology. MCF-7 cells alone formed
tight spheres within the gel of about 30 cells in size (Figure
2ai), whereas normal luminal cells (both primary and HB4a)
grew primarily as single cells or small loosely cohesive groups
(Figure 2aii). Inclusion of myoepithelial cells with either normal
or malignant luminal cell populations resulted in organisation
of the myoepithelial cells around the luminal population to form
a dual-cell co-unit (Figure 2aiii,iv). This organisation was
shown to be myoepithelial specific because co-culture of the
two luminal populations did not result in similar co-aggregation
(Figure 2av).
To investigate whether the organisation of these co-units was
an active homing process of myoepithelial cells around the
luminal population, the two cell populations were mixed at the
start of the experiment with no aggregation before resuspen-
sion in collagen. Gels were harvested at several time points to
assess the development of co-units. On D1 (Figure 2bi,ii) and
D3 (Figure 2biii,iv), the two cell types are intermingled, but by
D5 (Figure 2bv,vi) the cell populations began to aggregate
and by D7 (Figure 2bvii,viii) the co-units were formed, with
myoepithelial cells organised around the MCF-7 population
indicating an active process of spatial organisation that we
term 'homing'. Even by D7 no lumen formation was evident in
any of the cultures.
Phenotypic analysis of co-units
To analyse the structural and functional characteristics of the
dual-cell co-units, whole gel immunofluorescence was used to
examine a series of key markers. In all cases, a similar pattern
of expression was seen with primary cell populations and their
immortalised counterparts.
In the model of 'normal' breast, there was strong expression of
EMA limited to the central luminal HB4a population (Figure
3ai). E-cadherin was also strongly expressed by the luminal
cells (Figure 3aii). A zone of TN-C, localised to the myoepithe-
lial-gel interface was evident, indicative of endogenous base-
ment membrane production (Figure 3aiii). Similarly, strong
basal polarised expression of 4-integrin was seen in the
myoepithelial cells located in structures resembling
hemidesmosomes (Figure 3aiv).
In the MCF-7-myoepithelial co-cultures, a similar pattern of
myoepithelial homing around luminal population was
observed. The tumour cells expressed EMA and E-cadherin
expression was also maintained (Figure 3bi–ii); however, thereAvailable online http://breast-cancer-research.com/content/11/1/R3
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Figure 1
Characterisation of cell populations Characterisation of cell populations. The purity and phenotypic integrity of isolated primary and immortalised cell populations was confirmed by 
immunofluorescence. (a) Primary myoepithelial cells expressed of CK-14, CK-17, CK5/6, desmoglein (Dsg) 2, Dsg3, 4-integrin, vimentin, E-cad-
herin (E-Cad) and weak expression of -smooth muscle actin (SMA). No expression of the luminal associated epithelial membrane antigen (EMA) 
and CK-18 was observed. (b) Isolated luminal cells expressed EMA and CK-18 along with expression of Dsg-2 and E-cadherin. (c) Isolated fibrob-
lasts expression vimentin and a proportion of the cells expressed -SMA but there was no expression of epithelial, macrophage of endothelial asso-
ciated markers. The immortalised cell lines HB4a (luminal), MYO1089 (myoepithelial), HMFU19 (normal fibroblast) and hfff2 (fetal fibroblast) 
exhibited identical patterns of marker expression in comparison to their primary counterparts (data not shown).Breast Cancer Research    Vol 11 No 1    Holliday et al.
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were subtle differences in myoepithelial characteristics. Base-
ment membrane was less organised, present as punctate
deposits rather than a discrete layer around the myoepithelial
cells (Figure 3biii). In addition there was marked down-regula-
tion of 4-integrin expression, which was weakly expressed, or
in some cases negative, in these tumour co-units (Figure 3biv).
These characteristics were consistent features in co-cultures
generated from a minimum of six primary donors and 10 cell
line cultures.
Quantitative analysis of normal (primary n = 4; cell lines n = 4)
and MCF-7 (primary n = 3; cell lines n = 4) showed the aver-
age number of co-units per microscopic field was seven, with
no significant difference in the number of co-units between pri-
mary and cell line cultures, or luminal-myoepithelial and MCF-
7-myoepithelial co-cultures (Figure 3c). However, significant
differences were seen in the expression of the basal polarisa-
tion marker, 4-integrin and the basement membrane protein
TN-C. In luminal-myoepithelial co-units 78% of co-units
expressed  4-integrin compared with 20% of the MCF-7-
myoepithelial co-units (p  0.001, Figure 3d). A similar loss in
TN-C was observed in the MCF-7-myoepithelial co-units with
only 31% expressing the protein compared with 64% luminal-
myoepithelial cultures (p  0.001, Figure 3d).
Normal fibroblasts and tumour-associated fibroblasts 
have different effects on co-unit structure
To recapitulate the epithelial-stromal interactions present in
the in vivo situation, cultures were constructed to incorporate
a fibroblast population with the epithelial-myoepithelial co-unit.
Incorporation of normal fibroblasts from reduction mammo-
plasty tissue, or the 'normal' fibroblast cell line HMFU19
revealed a similar pattern of co-unit formation to those cultures
without a fibroblast population over the same time period. At
D1 (Figure 4ai,ii) the three cell populations were intermingled,
and on D3 (Figure 4aiii,iv) there was some clustering of luminal
cells, which became more marked by D5 (Figure 4av,vi). At D7
myoepithelial cells had homed around the luminal cell clusters
Figure 2
Generation of epithelial-myoepithelial co-units Generation of epithelial-myoepithelial co-units. Cell populations were cultured in collagen gels for seven days with preaggregation of the luminal cell 
population. (a) (a)i MCF-7 cells alone formed tight spheres whereas (a)ii luminal cells formed loosely cohesive structures. Co-culture of (a)iii primary 
luminal/myoepithelial cells and (a)iv MCF-7/myoepithelial cells showed organisation of the myoepithelial cells (cell trackered in red) around the lumi-
nal population (nuclear labelling blue with 4',6-diamidino-2-phenylindole (DAPI)) forming a dual-cell co-unit. Co-unit formation was shown to be 
myoepithelial specific by the lack of organisation of (a)v luminal cells (cell trackered red) around pre-aggregated MCF-7 cells. A time course to show 
co-unit formation from cells without prior preaggregation was performed. (b) At (b)i,ii day 1 and (b)iii,iv day 3 MCF-7 cells and primary myoepithelial 
cells were intermingled. At (b)v,vi day 5 cells began to aggregate and by (b)vii,viii day 7 co-units were formed suggesting that organisation of co-
units is through an active homing process.Available online http://breast-cancer-research.com/content/11/1/R3
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with fibroblasts located around the co-unit having no signifi-
cant effect on the architecture of the co-unit structure (Figure
4avii,viii).
In contrast, addition of TAFs to the cultures led to disruption of
the co-units, with loss of homing of the myoepithelial cells and
mixing of all three cell populations (Figure 4b). Quantitative
analysis of these cultures revealed that the average number of
co-units per field is significantly decreased from 7.5 in the
presence of the normal fibroblasts to 1.2 in the presence of
TAFs (p  0.001, Figure 4c)
Experiments were performed where conditioned medium from
normal fibroblasts or TAFs was added to the co-cultures in
place of the fibroblast populations. The effect seen in the pres-
ence of the fibroblasts is replicated by their conditioned
media, with TAF conditioned medium (Figure 4dii), but not
with normal fibroblast conditioned medium (Figure 4di) dis-
rupting epithelial co-units.
Inhibiting HGF receptor and MMPs can restore epithelial 
co-unit formation
To investigate potential mechanisms by which TAFs may be
disrupting co-unit formation a series of experiments was car-
Figure 3
Phenotypic analysis of co-units Phenotypic analysis of co-units. (a) Co-units formed by primary myoepithelial cells (red) surrounding the normal luminal epithelial cells exhibited 
polarity detected by luminal expression of epithelial membrane antigen (EMA) localised to (a)i, green stain: the epithelial population. (a)ii, green stain: 
E-cadherin was expressed at cell-cell junctions. (a)iii, green stain: Myoepithelial cells laid down the matrix protein tenascin-C (TN-C) and (a)iv, green 
stain: expressed 4-integrin in hemidesmosome like structures at the myoepithelial-gel interface. (b) In the myoepithelial/MCF-7 co-units, (b)i, green 
stain: MCF-7 tumour cells expressed EMA and (b)ii, green stain: E-cadherin. A less organised basement membrane was present, (b)iii, green stain: 
shown by TN-C staining and (b)iv, green stain: marked down-regulation or loss of 4-integrin expression was observed. Quantitation of co-unit for-
mation was carried by counting the number of co-units in 10 microscopic fields per culture to give an average number of co-units/field. A co-unit was 
defined as aggregated luminal or MCF-7 cells which were at least 70% enclosed by myoepithelial cells. (c) No significant difference in the two types 
of co-units was observed. To quantitate the presence of 4-integrin and TN-C the percentage of co-units expressing the proteins were counted and 
expressed as a percentage of total co-units. (d) A significant decrease in the levels of 4 integrin and TN-C were observed in the MCF-7-myoepithe-
lial cell cultures compared with the luminal-myoepithelial cell cultures. (p = 0.001).Breast Cancer Research    Vol 11 No 1    Holliday et al.
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ried out to analyse the potential involvement of HGF-c-met
interactions and MMP activity. Inhibitors to either the HGF
receptor (c-met) and a broad spectrum MMP inhibitor were
incorporated into MCF7/myoepithelial/TAF cultures, either
alone or in combination, and the frequency of co-unit formation
was assessed in comparison to vehicle-only controls (n = 3 for
each condition). A greater number of co-units were formed in
the presence of either inhibitor compared with the vehicle con-
trol (Figure 5a). The presence of the c-met inhibitor signifi-
cantly increased the average number of co-units from two in
the control group to 4.5 (p = 0.016). This effect was greater
in the presence of the MMP inhibitor where an average of
seven co-units formed (p = 0.001). A combination of the two
inhibitors also resulted in significantly higher numbers of co-
units than controls (p = 0.001) but this was not significantly
greater than in the presence of MMP inhibitor alone (Figure
5b).
Discussion
There is growing evidence for the role of the microenvironment
in cancer progression. Fibroblasts clearly influence tumour
behaviour [1-3] and, in the breast, myoepithelial cells also
appear to be a major regulator of tumour progression [7,8].
Figure 4
Effect of fibroblasts on co-unit structure Effect of fibroblasts on co-unit structure. Incorporation of normal breast fibroblasts into myoepithelial/MCF-7 cultures. Non pre-aggregated cells 
were mixed and cultured in a collagen gel for up to one week to establish if fibroblasts influence epithelial co-unit formation. (a) (a)i,ii: At day 1, MCF-
7 cells, myoepithelial cells (cell trackered red) and fibroblasts (cell trackered green) were intermingled. (a)iii,iv: By day 3, MCF-7 clusters were begin-
ning to form and (a)v,vi these were more prominent by day 5. (a)vii,viii: Co-units were formed by day 7 with normal fibroblasts located around the epi-
thelial structures (low power image). Incorporation of tumour-associated fibroblast (TAF) into myoepithelial/MCF-7 into 7 day co-cultures. (b) (b)i,ii: 
The homing of myoepithelial cells to MCF-7 cells is disrupted on addition of TAFs, with the cells reverting to an intermingled mixed population. (b)iii: 
The effect on the culture is particularly evident at low-power magnification. (c) Quantitation of co-units revealed a decrease from 7.5 to 1.2 in the 
presence of TAFs compared with normal fibroblasts (p = 0.001). (d) These effects could be replicated in cultures grown for seven days in the pres-
ence of conditioned medium from the fibroblast populations with disruption of co-unit architecture (d)ii in the presence of TAF conditioning media 
but not (d)i normal fibroblast conditioning media.Available online http://breast-cancer-research.com/content/11/1/R3
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Here, we describe for the first time, a 3D heterotypic co-cul-
ture model including two major cellular components of the
breast microenvironment. This recapitulates the organisation
and functional differentiation of the breast, and will provide a
valuable tool to dissect the complex interactions between
these cell populations in order to understand the factors deter-
mining breast cancer behaviour.
There is a paucity of well-characterised, validated cell lines to
model the breast microenvironment; therefore, primary iso-
lated populations remain the 'gold standard'. Thus, central to
this study was the need to isolate pure populations of primary
luminal, myoepithelial and fibroblast populations and ensure
that their phenotype is maintained in culture. No single marker
can reliably distinguish between these breast populations. For
example, vimentin and -SMA will label both myoepithelial and
fibroblast populations, and while the cytokeratin profile is fre-
quently used to differentiate luminal and myoepithelial breast
populations in tissue, their expression pattern may not be as
stable in cells in culture [22]. We therefore employ a compre-
hensive panel of markers to characterise the phenotype of iso-
lated cell populations. Using this combination of markers our
findings confirm more than 95% purity of each myoepithelial,
luminal and fibroblast population. Specifically, the main con-
taminants of the stromal component, namely, endothelial cells,
pericytes and inflammatory cells were all ruled out on immun-
ofluorescent profiling [23] while the cell populations largely
maintained their in vivo characteristics. Some differences
were noted, particularly down-regulation of -SMA in the
myoepithelial cell cultures, in keeping with other studies [24].
Although primary cells represent the ideal, it is important to
attempt to generate viable alternatives, owing to the inherent
difficulties of working with this material. We obtained cell lines
generated from luminal, myoepithelial and fibroblast popula-
tions isolated in a similar fashion to our primary cells and
immortalised by transduction with SV40 large T antigen [19].
Figure 5
Effect of inhibitors on fibroblast-induced co-unit disruption Effect of inhibitors on fibroblast-induced co-unit disruption. (a) Cultures were generated with MCF-7 cells, myoepithelial cells and tumour-associated 
fibroblasts (TAFs) without prior aggregation, and grown in the (a)i,ii presence of dimethyl sulfoxide (DMSO) (10 M), a specific inhibitor for c-met, 
(a)iii,iv the receptor for HGF, (PHA 665752, 100 nM), (a)iv,vii a broad spectrum matrix metalloproteinase (MMP) inhibitor (10 M) individually, or 
(a)vii,viii in combination. Inhibitors were replenished at two-day intervals and the cultures harvested at seven days. (b) In the vehicle control cultures 
exhibited an average of two co-units per microscopic field. This was significantly increased in the presence of the c-met inhibitor (average co-units 
4.6, p = 0.016), the MMP inhibitor (average co-units 7, p  0.001) and the inhibitors in combination (average co-units 7.5, p = 0.001).Breast Cancer Research    Vol 11 No 1    Holliday et al.
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These cell populations exhibited close phenotypic integrity in
comparison to their primary counterparts. In order to incorpo-
rate a tumour cell population in the cultures, MCF-7 breast
cancer cell line was chosen as a representative, well-charac-
terised luminal-like cell.
Co-aggregation of the epithelial components of the breast
resulted in localisation of myoepithelial cells around luminal
cells to form a 'co-unit', analogous to the in vivo situation.
Incorporation of cells into co-cultures without prior co-aggre-
gation led to a similar organisation of myoepithelial cells
around the luminal population, suggesting that this is an active
'homing' process. Homing has been shown to be dependant
on spatial specificity determined by desmosomal proteins and
can be disrupted using peptides to myoepithelial specific des-
moglein-3 and desmocollin (Dsc) 3 [25]. In keeping with this,
homing was shown to be myoepithelial specific with no evi-
dence of localisation of luminal cells around MCF-7 cells. Sim-
ilar co-units were generated when either primary myoepithelial
cells or the myoepithelial cell line was used supporting the
validity of this line. Myoepithelial cells form co-units with both
normal and MCF-7 cells but subtle differences were observed
between the two culture systems, mainly at the junction of the
basal surface of the myoepithelial cells and the basement
membrane. In the 'normal' co-units myoepithelial cells were
shown to lay down their own basement membrane protein,
demonstrated here with TN-C and previously described by
other groups in 2D cultures of myoepithelial cells [26]. There
was polarised expression of -integrin located at the basal
interface between the myoepithelial cells and the basement
membrane in structures resembling hemidesmosomes
[26,27]. The most striking difference identified in the presence
of a malignant luminal population was disruption of basement
membrane and loss of 4-integrin. Basement membrane has
been shown to be altered around DCIS [6,27], and loss of
hemidesmosomes has also been reported in DCIS tissue [27].
This correlation between the in vitro models described here
and observations of DCIS clinical samples supports the valid-
ity of these co-units as models of normal and DCIS-like breast.
To generate further complexity, fibroblasts, implicated in
breast cancer progression, were also incorporated into the
model. It is known that TAFs are phenotypically and function-
ally different to normal fibroblasts; therefore, fibroblasts from
normal donors and patients with breast cancer were exam-
ined, together with two fibroblast cell lines that reflect 'normal'
and 'tumour-like' fibroblasts. Normal fibroblasts homed around
the epithelial co-units and did not disrupt the glandular archi-
tecture; however, the TAFs led to complete disruption of co-
unit organisation. The ability of conditioned media from these
fibroblasts to recreate this suggests that the effect is mediated
at least in part by soluble factors released from the fibroblasts.
Tumour-associated fibroblasts are known to release higher
levels of proteases such as urokinase plasminogen activator
and MMPs than their normal counterparts [5,28]. Additionally
HGF is up-regulated in breast cancer and also released at
higher levels by these fibroblasts [2,29].
We therefore used this co-culture model system to investigate
the potential involvement of MMPs and HGF signalling in
mediating the disruption of normal architecture. The incorpo-
ration of either a broad spectrum inhibitor to MMPs or a c-met
inhibitor partially abrogated the disruptive effect of TAFs or
conditioned medium on co-unit formation. The effect was sig-
nificantly greater with the MMP inhibitor than with c-met inhibi-
tion which suggests that, in this system, MMPs play the more
prominent role. Several stromal-derived MMP members have
been implicated in playing a role in the transition of DCIS to
invasive disease, including MMP-13 [30], MMP-26-mediated
activation of MMP-9 [31], and MMP-2, -3 and -11 [32]. The
model system described here provides a mechanism to dis-
sect the role of these factors in the control of cellular interac-
tions and tissue architecture.
Conclusion
The models described here are the first to incorporate not only
luminal and fibroblast populations but also the myoepithelial
population that in vivo forms the interface between the epithe-
lial and stromal compartments. While lacking the full complex-
ity of mouse model systems, this model has several
advantages including easy manipulation of individual cell pop-
ulations, shorter timescale and cost. Furthermore, these mod-
els could easily be adapted to incorporate other components
of the microenvironment including inflammatory or endothelial
cell populations. Of particular importance to the development
of human models of cancer, these co-cultures can be set up
and maintained in a completely animal-free environment by
adapting the reagents used.
In establishing these models, we have identified differences in
behaviour between normal and tumour-associated cell popula-
tions. These raise important questions about the role of these
cell interactions in generating phenotypic and functional
changes that may influence tumour behaviour. Our preliminary
evidence suggests a role for MMP in mediating the disruption
of normal cellular interactions and demonstrates how these
models could be used to dissect such interactions, as well as
their potential for use in the identification and screening of
novel therapeutic targets.
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